Toggle light / dark theme

I’m excited to share my interview with Jakub Dymek on #transhumanism in the new edition of The Aspen Institute (Eastern Europe) quarterly Aspen Review magazine.


Let’s think about this: what happens when sometime in the future the whole generation of Chinese kids have higher IQs than their American peers, because they’re technologically hardwired for that? Will this be a national security issue? This is a global security issue—says Zoltan Istvan in an interview with Jakub Dymek.

JAKUB DYMEK: You are a transhumanist—member of a movement endorsing technologically augmented advancement of human species and using technology to extend our capabilities. What does transhumanist thinking bring into the world of policy debate in the US and worldwide and how politically influential it is?

ZOLTAN ISTVAN: Transhumanism influences politics today only a little bit. But at the same time, transhumanist movement grows exponentially, like 1000% every year. So I think its implications for the policy debate here in the US and globally will only grow in scale and importance, obviously. Transhumanism can define policy debate of the future, of that I’m sure. President Trump can say today that manufacturing jobs and jobs in general are lost because of immigrants. But he wouldn’t be able to say the same thing up until 2020 campaign, because it’s simply not true, and more people realize the simple fact that jobs aren’t lost to immigration, but automation. It’s tech “stealing the jobs” he is going to have to say then. And you cannot build a wall to stop technology from spreading. This is how transhumanism is already shaping this debate. And it goes beyond jobs.

Every three seconds, a person somewhere in the world breaks a bone due to osteoporosis—a progressive disease that decreases bone density, making bones weak and fragile. Osteoporotic fractures greatly reduce quality of life, and immobilization following a fracture can lead to further bone loss which puts these patients at risk for breaking another bone.

When SpaceX CRS-11 launched to the space station last June, it carried 40 mice to the ISS National Lab for a mission aimed at improving treatment for the millions of people with osteoporosis back on Earth. The Rodent Research (RR)-5 mission successfully proved the robustness of a new potential osteoporosis therapy based on a naturally produced protein, NELL-1, and also led to significant improvements in the delivery of the therapy.

chia soo laptop

Read more

Dreeming big.


Dreem Announces $35 Million Financing from lead investors Johnson & Johnson Innovation and Bpifrance (press release):

“Dreem, a neurotechnology company, today announced the closing of a new round of funding, raising $35 million USD to rapidly accelerate product development, invest in strategic research and development, and advance the future of sleep technology. Last year, Dreem introduced a comprehensive solution to address a suite of sleep problems and enhance the quality of rest during the night. The Dreem headband monitors brain activity to track sleep accurately and uses auditory stimulation as a medium to help people fall asleep faster, get deeper sleep, and wake up refreshed.

With the $35 million investment, led by strategic investor JJDC, Dreem will bring next-generation sleep technology to markets across the globe and continue to invest in R & D for future sleep-related scientific discoveries and technological innovations … Dreem previously raised a total of $22 million, from billionaire French entrepreneur Xavier Niel, entrepreneur and biotech investor Dr. Laurent Alexandre, and one of the top French insurance leaders — MAIF. With additional investment from JJDC and Bpifrance, Dreem has raised nearly $60 million in less than four years.”